Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050043529A1
SERIAL NO

10831775

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to adjuvants, and in particular to methods and products utilizing a synergistic combination of immunostimulatory oligonucleotides having at least one unmethylated CpG dinucleotide (CpG ODN) and a non-nucleic acid adjuvant. Such combinations of adjuvants may be used with an antigen or alone. The present invention also relates to methods and products utilizing immunostimulatory oligonucleotides having at least one unmethylated CpG dinucleotide (CpG ODN) for induction of cellular immunity in infants.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OTTAWA HOSPITAL RESEARCH INSTITUTEOTTAWA ON K1N 6N5

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Heather L Ottawa, CA 21 2015
Krieg, Arthur M Wellesley, MA 154 11149
Schorr, Joachim Hilden, DE 20 1430

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation